A review of a priori regression models for warfarin maintenance dose prediction.
A number of a priori warfarin dosing algorithms, derived using linear regression methods, have been proposed. Although these dosing algorithms may have been validated using patients derived from the same centre, rarely have they been validated using a patient cohort recruited from another centre. In...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0114896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850125192326545408 |
|---|---|
| author | Ben Francis Steven Lane Munir Pirmohamed Andrea Jorgensen |
| author_facet | Ben Francis Steven Lane Munir Pirmohamed Andrea Jorgensen |
| author_sort | Ben Francis |
| collection | DOAJ |
| description | A number of a priori warfarin dosing algorithms, derived using linear regression methods, have been proposed. Although these dosing algorithms may have been validated using patients derived from the same centre, rarely have they been validated using a patient cohort recruited from another centre. In order to undertake external validation, two cohorts were utilised. One cohort formed by patients from a prospective trial and the second formed by patients in the control arm of the EU-PACT trial. Of these, 641 patients were identified as having attained stable dosing and formed the dataset used for validation. Predicted maintenance doses from six criterion fulfilling regression models were then compared to individual patient stable warfarin dose. Predictive ability was assessed with reference to several statistics including the R-square and mean absolute error. The six regression models explained different amounts of variability in the stable maintenance warfarin dose requirements of the patients in the two validation cohorts; adjusted R-squared values ranged from 24.2% to 68.6%. An overview of the summary statistics demonstrated that no one dosing algorithm could be considered optimal. The larger validation cohort from the prospective trial produced more consistent statistics across the six dosing algorithms. The study found that all the regression models performed worse in the validation cohort when compared to the derivation cohort. Further, there was little difference between regression models that contained pharmacogenetic coefficients and algorithms containing just non-pharmacogenetic coefficients. The inconsistency of results between the validation cohorts suggests that unaccounted population specific factors cause variability in dosing algorithm performance. Better methods for dosing that take into account inter- and intra-individual variability, at the initiation and maintenance phases of warfarin treatment, are needed. |
| format | Article |
| id | doaj-art-3d1dd413ba044213b9e678da7e80fbc9 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-3d1dd413ba044213b9e678da7e80fbc92025-08-20T02:34:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11489610.1371/journal.pone.0114896A review of a priori regression models for warfarin maintenance dose prediction.Ben FrancisSteven LaneMunir PirmohamedAndrea JorgensenA number of a priori warfarin dosing algorithms, derived using linear regression methods, have been proposed. Although these dosing algorithms may have been validated using patients derived from the same centre, rarely have they been validated using a patient cohort recruited from another centre. In order to undertake external validation, two cohorts were utilised. One cohort formed by patients from a prospective trial and the second formed by patients in the control arm of the EU-PACT trial. Of these, 641 patients were identified as having attained stable dosing and formed the dataset used for validation. Predicted maintenance doses from six criterion fulfilling regression models were then compared to individual patient stable warfarin dose. Predictive ability was assessed with reference to several statistics including the R-square and mean absolute error. The six regression models explained different amounts of variability in the stable maintenance warfarin dose requirements of the patients in the two validation cohorts; adjusted R-squared values ranged from 24.2% to 68.6%. An overview of the summary statistics demonstrated that no one dosing algorithm could be considered optimal. The larger validation cohort from the prospective trial produced more consistent statistics across the six dosing algorithms. The study found that all the regression models performed worse in the validation cohort when compared to the derivation cohort. Further, there was little difference between regression models that contained pharmacogenetic coefficients and algorithms containing just non-pharmacogenetic coefficients. The inconsistency of results between the validation cohorts suggests that unaccounted population specific factors cause variability in dosing algorithm performance. Better methods for dosing that take into account inter- and intra-individual variability, at the initiation and maintenance phases of warfarin treatment, are needed.https://doi.org/10.1371/journal.pone.0114896 |
| spellingShingle | Ben Francis Steven Lane Munir Pirmohamed Andrea Jorgensen A review of a priori regression models for warfarin maintenance dose prediction. PLoS ONE |
| title | A review of a priori regression models for warfarin maintenance dose prediction. |
| title_full | A review of a priori regression models for warfarin maintenance dose prediction. |
| title_fullStr | A review of a priori regression models for warfarin maintenance dose prediction. |
| title_full_unstemmed | A review of a priori regression models for warfarin maintenance dose prediction. |
| title_short | A review of a priori regression models for warfarin maintenance dose prediction. |
| title_sort | review of a priori regression models for warfarin maintenance dose prediction |
| url | https://doi.org/10.1371/journal.pone.0114896 |
| work_keys_str_mv | AT benfrancis areviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT stevenlane areviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT munirpirmohamed areviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT andreajorgensen areviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT benfrancis reviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT stevenlane reviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT munirpirmohamed reviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction AT andreajorgensen reviewofaprioriregressionmodelsforwarfarinmaintenancedoseprediction |